Drug intelligence / Profile preview

ArthroMicroPerMed

Development stage
Preclinical
Lead developer
Biohellenika
Modality
Peptides, Stem Cell Therapies → Cell Therapies, Hydrogel Systems → Drug Delivery Systems
Administration
Intraarticular
01

Overview

ArthroMicroPerMed is an experimental regenerative therapy developed by Biohellenika for the treatment of osteoarthritis and joint damage. The platform utilizes a personalized medicine approach, combining autologous mesenchymal stem cells (MSCs) isolated from the patient's hip or knee with an injectable "smart" biomaterial scaffold. This scaffold is composed of elastin and fibroin hydrogels and is functionalized with Bone Morphogenetic Protein-7 (BMP7) and Transforming Growth Factor-beta (TGF-β) peptides to promote chondrogenesis and cartilage regeneration. Additionally, the scaffold incorporates collagen and laminin peptides to recruit endogenous stem cells and poly-diacetylene (PDA) sensors for the real-time detection of bacterial infections. The program also investigates the role of microbiome metabolites in the pathogenesis of osteoarthritis to optimize therapeutic outcomes.

Other names
Biohellenika-BMP7-TGF-β-cell therapyArthro-Micro-PerMed

Beyond the preview

Go deeper on ArthroMicroPerMed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArthroMicroPerMed.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call